CJA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Submit a scholarly reply
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by JENKINS, L. C.
Right arrow Articles by GRAVES, H. B.
Right arrow Search for Related Content
PubMed
Right arrow Articles by JENKINS, L. C.
Right arrow Articles by GRAVES, H. B.

Canadian Journal of Anesthesia, Vol 12, 1-10, Copyright © 1965 by Canadian Anesthesiologists' Society

Clinical, Biochemical, and Haemodynamic Studies in Man during Refractory Hypotension

LEONARD C. JENKINS B.A., M.D., C.M., F.R.C.P.(C)1, W. A. DODDS M.D.1, and H. B. GRAVES B.A., M.D., C.M., F.R.C.P. (C)1

1 Department of Anaesthesia, Vancouver General Hospital, and the Faculty of Medicine, University of British Columbia, Vancouver, British Columbia

1. There appear to be four main clinical postoperative presentations in which patients most commonly have refractory hypotension: (i) thos4 with unrecognized, persisting blood-volume deficit, (ii) those with severe sepsis, (iii) those with complicating myocardial failure, (iv) those who have had extensive surgical procedures with local complications.

2. These patients commonly present with a coexisting metabolic acidosis and/or hyponatraemia.

3. In view of these observations, it is suggested that in the treatment of these patients with refractory hypotension blood and fluid loss be fully replaced. A persisting, unrecognized blood-volume deficit often in fact still exists in these patients. Central venous pressure (CVP) can be a useful guide;to this replacement therapy. If during volume replacement the arterial bloodl pressure rises, before the CVP, then in all likelihood volume deficit hypotension shock existed. If, however, CVP increases steadily and before the arterial blood pressure rises, then the transfusion rate must be decreased and chemical therapy with cardiotonic agents used, in the form of a digitalis preparation, isopropyl norepinephrine, or calcium chloride or gluconate. In either case concurrent correction of the acid-base defect is carried out. Metabolic acidosis and hyponatraemia can be treated effectively with NaHCO3. Appropriate antibacterial therapy is given where indicated.

4. Patients considered to be in a potentially "irreversible" or irefractory hypotensive status may, in fact, show surprising reversibility and survivability, once the pathophysiologic defect is recognized and repaired.

Note:

Presented in part at the Ánnual Meeting, Western Divisions, Canadian Anaesthetists' Society, April, 1964.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1965 by the Canadian Anesthesiologists' Society.